Axatilimab With or Without Azacitidine for the Treatment of Patients With Advanced Phase Myeloproliferative Neoplasms, Myeloproliferative Neoplasm/Myelodysplastic Syndrome Overlap or High Risk Chronic Myelomonocytic Leukemia
Conditions
- Atypical Chronic Myeloid Leukemia
- Chronic Myelomonocytic Leukemia
- Myelodysplastic/Myeloproliferative Neoplasm
- Recurrent Myelodysplastic/Myeloproliferative Neoplasm
- Recurrent Myeloproliferative Neoplasm
- Refractory Chronic Myelomonocytic Leukemia
- Refractory Myelodysplastic/Myeloproliferative Neoplasm
- Refractory Myeloproliferative Neoplasm
Interventions
- BIOLOGICAL: Axatilimab
- DRUG: Azacitidine
- PROCEDURE: Biospecimen Collection
- PROCEDURE: Bone Marrow Aspiration and Biopsy
- OTHER: Survey Administration
Sponsor
Uma Borate
Collaborators